L8 Mitochondrial Pharmacology Flashcards

1
Q

4 main compartments of mitochondria

A
  • outer membrane
  • inner membrane space
  • inner membrane (folded into cristate, machinery for OXPHOS)
  • matrix (location for metabolic reactions)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How many genes does mtDNA encode?

A

37 (of which 13 are involved in the synthesis of subunits of respiratory chain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 main roles of mitochondria

A
  1. Energy production by OXPHOS
  2. Central carbon metabolism
  3. Biosynthesis of intermediates for cell growth & function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are primary mitochondrial diseases?

A

A group of rare genetic metabolic disorders caused by mutations in nuclear or mitochondrial DNA, which result in malfunctioning mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mutations in mtDNA only affect…

A

the integrity of the respiratory chain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mutations in nuclear DNA disturb…

A

OXPHOS by impairing mitochondrial protein import, translation & assembly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

When do secondary mitochondrial diseases occur?

A

When other pathological processes negatively impact mitochondrial homeostasis (age-related conditions e.g. neurodegeneration, metabolic disorders, HF)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Main role of mitochondria

A

energy production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

OXPHOS can be divided into 2 basic parts. What are they?

A

The redox steps (ETC) and the energy-generation events (chemiosmosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Main steps of oxidative phosphorylation

A
  • Delivery of electrons by NADH and FADH2
  • Electron transport and proton pumping
  • Splitting of oxygen to form water
  • ATP synthesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Complex I donates its electron (from NADH) to __

A

coenzyme A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

FADH2 donates its electron to __

A

Complex II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Coenzyme A donates electrons to __

A

Complex III (cytochrome C oxidoreductase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Oxygen collects electrons from __

A

Complex IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mitochondrial membrane potential is vital for…

A

maintaining the physiological function of the ETC to produce ATP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Significant loss in mitochondrial membrane potential results in…

A

depletion in cellular energy and subsequent cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Mitochondrial dysfunction causes significant changes in __ and __

A

cellular energy metabolism and ROS generation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Examples of harmful consequences of excessive mitochondrial ROS production

A
  • lipid oxidation
  • mtDNA/RNA damage
  • protein oxidation
  • Ca²⁺-dependent activation of MPTP
  • cytochrome C release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cytochrome C release from mitochondria will induce __

A

apoptosis (via activation of the intrinsic pathway)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Mitochondrial homeostasis is preserved by the fine coordination between two opposing processes:

A
  1. Generation of new mitochondria by mitochondrial biogenesis
  2. Removal of damaged mitochondria by mitophagy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are the consequences of mitochondrial biogenesis?

A
  • Increased OXPHOS capacity
  • Diminishment of pathological oxidative stress
  • Repair of mitochondrial-associated dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Important stimulant of mitochondrial biogenesis

A

PGC1α

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Mitochondrial dynamics

A

Fusion and fission

24
Q

Mitochondrial fusion is regulated by…

A

proteins such as mitofusins (MFN1 and MFN2) and optic atrophy protein 1 (OPA1)

25
Q

Mitochondrial fission is controlled by…

A

proteins such as dynamic-related protein (DRP1)

26
Q

Difference between mitochondrial fusion and fission

A

Fusion usually results if there are defective elements in each mitochondrion, which leads to replication of mtDNA during biogenesis. Whereas fission does not involve replication, mtDNA from each mitochondrion is used.

27
Q

Rationale for targeting mitochondria

A

Common patterns of how dysfunctional mitochondria contribute to pathogenesis of secondary diseases:
- Excessive ROS
- Disrupted Ca²⁺ homeostasis
- Defective mito biogenesis
- Disrupted mito dynamics
- Inappropriate apoptosis
- Reduced NAD⁺
- Alterations in mito signalling pathways

28
Q

6 potential therapeutic strategies for how small molecules can affect mitochondria (either directly or indirectly)

A
  1. OXPHOS modulators
  2. Repairing or preventing damage
  3. Inducing mitochondrial biogenesis
  4. Enhancing quality control by stimulating degradation of damaged mitochondria
  5. Co-opting mitochondrial function to induce cell death
  6. Altering mitochondrial signalling
29
Q

A widely used approach to target mitochondria is to utilise…

A

the mitochondrial membrane potential, which drives the accumulation of lipophilic cations within mitochondria

30
Q

Example of a lipophilic cation that’s able to pass through biological phospholipid bilayers

A

Triphenyl-phosphonium (TPP)

31
Q

By conjugation to TPP, bioactive molecules can be…

A

delivered into the mitochondrial matrix in vivo, provided they are not too polar

32
Q

Greatest focus of directly-targeted mitochondrial therapeutics

A

OXPHOS modulators

33
Q

Examples of OXPHOS modulators

A
  • Idebenone (Raxone)
  • Imeglimin
34
Q

What is Idebenone?

A
  • synthetic short chain analogue of coenzyme Q10 with enhanced solubility & PK
  • lipophilic electron carrier (predicted to act as an antioxidant in transfer of electrons from Complex II to III)
35
Q

Idebenone had disappointing results in clinical trials for which indications?

A

Alzheimer’s disease and Friedreich’s ataxia

36
Q

Idebenone has promising initial results for treatment of __

A

Leber’s hereditary optic neuropathy (LHON) - primary mito disease (vision loss due to mutations in mtDNA)

37
Q

Idebenone is under review by EMA for treatment of…

A

DMD patients who are not using glucocorticoids

38
Q

Preclinical evidence has shown that Imeglimin is…

A

A competitive inhibitor of Complex I and restores the hyperglycaemia-induced reduction in Complex III content and activity. This lowers reverse electron flow-associated ROS production and improves mitochondrial respiration.

39
Q

Targeting mitochondrial pyruvate carrier (MPC) controls…

A

import of pyruvate into matrix from inner mitochondrial membrane, linking glycolysis to OXPHOS

40
Q

Dysregulated mitochondrial pyruvate uptake plays an important role in…

A

non-alcoholic fatty liver disease (NAFLD) - secondary mito disease

41
Q

Pharmacological inhibition of MPC is now being explored as a potential therapeutic to correct mitochondrial dysfunction in __

A

NAFLD

42
Q

__-sparing glitazone derivatives have been developed to improve the therapeutic effect of glitazone in non-alcoholic steatohepatitis (NASH) patients specifically through inhibition of MPC.

A

PPAR𝛾

43
Q

A burst of __ from mitochondrial respiratory chain upon reperfusion initiates a cascade of tissue damage

A

superoxide

44
Q

Mitochondrial dysfunction is a key component of __

A

heart failure

45
Q

Mitochondrial antioxidants have had disappointing results in __

A

CVD

46
Q

Drugs to protect mitochondria

A
  • Antioxidants to reduce oxidative damage
  • Replenish NAD⁺ stocks (nicotinamide)
  • Develop drugs to activate chaperones or proteases within mitochondria
47
Q

Drugs to induce mitochondrial biogenesis

A
  1. PPAR𝛾 can be activated directly by pioglitazone, which increases PGC1α expression
    - Pioglitazone metabolite, Leriglitazone, in Phase II/III trial for Friedreich’s ataxia
  2. Activation of AMPK can indirectly activate PGC1α
    - PXL770 (AMPK activator) in Phase II trial for NASH
48
Q

Cancer cells can evade death owing to defective induction of the mitochondrial __ pathway by over-expressing __ .

A

apoptotic
BCL-2

49
Q

Mitochondrial apoptosis is induced by…

A

mitochondrial outer membrane permeabilisation (MOMP) and the subsequent release of pro-apoptotic factors such as cytochrome C into the cytosol

50
Q

What pro-apoptotic proteins form the MOMP pore?

A

BCL-2 associated X (BAX) and BCL-2 homologous antagonist/killer (BAK)

51
Q

Example of a BH3-only pro-apoptotic protein

A

BID

52
Q

An example of a BH3 mimetic drug that counteracts the suppression of apoptosis in cancer cells by excess BCL-2 anti-apoptotic members

A

Venetoclax

53
Q

Venetoclax administered with __ is an effective treatment for CLL

A

Obinutuzumab (anti-CD20 mAb)

54
Q

The antioxidants with the highest therapeutic potential target…

A

glutathione (GSH) and thioredoxin (Trx) redox systems

55
Q

Novel antioxidant agent that targets the Trx system to reduce ROS-induced cell death

A

Sonlicromanol

56
Q

Sonlicromanol recently granted orphan drug designation for __

A

maternally inherited diabetes and deafness/MIDD (caused by a mutation in mtDNA)